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Supplementary materials and methods 
 
Cohorts 
Approval by local institutional review boards was obtained in all studies and informed consent 
was obtained from all participants. 
 
1. ALSPAC1 — United Kingdom. The Avon Longitudinal Study of Parents and their Children 
(ALSPAC) is a longitudinal population-based birth cohort that recruited pregnant women 
residing in Avon, UK, with an expected delivery date between 1st April 1991 and 31st December 
1992. 14,541 pregnant women were initially enrolled with 14,062 children born. Biological 
samples including DNA have been collected for 10,121 of the children from this cohort. Ethical 
approval was obtained from the ALSPAC Law and Ethics committee and relevant local ethics 
committees, and all parents provided written informed consent. IPIP data was available for 6,076 
children (3,099 females; 51.0%). Mean age was 13.8 years (SD=0.21). The data were collected 
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between 2005 and 2006. 4,705 children had both valid genotype and extraversion data. The study 
website contains details of all the data that is available through a fully searchable data dictionary 
(http://www.bris.ac.uk/alspac/researchers/data-access/data-dictionary). 
 
2. BLSA2 — United States of America. The Baltimore Longitudinal Study of Aging (BLSA) is an 
ongoing multidisciplinary study of community-dwelling volunteers. For this study, we examined 
data from 1,917 participants (952 women) of European descent that completed the NEO-PI-R 
questionnaire. In this sample, mean age was 58.3 years (SD=16.6). The mean age of the males 
was 56 years (SD=16.7) and of the females 60.7 years (SD=16.3). The data were collected 
between 1991 and 2010.  
 
3. BRESCIA – Italy. The Brescia cohort consisted of 177 unrelated healthy volunteers (89 female 
and screened for DSM-IV Axis I disorders by expert psychologists using the Mini-International 
Neuropsychiatric Interview (M.I.N.I.). Only healthy volunteers without a history of drug or 
alcohol abuse or dependence and without a personal or first-degree family history of psychiatric 
disorders were enrolled in the study. Subjects who obtained a score lower than 27/30 in the Mini 
Mental State Examination (M.M.S.E.) were excluded as well. Furthermore, only participants 
with Italian descent (all four grandparents Italian) could participate. The personality traits were 
assessed by the Italian version of the TCI, a 240-item, true-false self-report questionnaire. The 
mean age of the sample was 47.58 years (SD=16.30; women M=47.08, SD=17.31, men 
M=48.09, SD=15.29). The data were collected between 2007 and 2011. 
 
4. CHICAGO3 – United States of America.  
The Chicago cohort comes from a genetic study in which 311 healthy Caucasian adults, aged 18-
35 years, were tested for response to an acute dose of d-amphetamine. They were recruited from 
the community and underwent medical and psychiatric screening before the study.  Participants 
completed the Multiphasic Personality Inventory- Brief Form during screening, and they were 
genotyped using the Affymetrix 6.0 array. The sample consisted of 166 males (mean age 23.6, 
SD=3.7) and 145 females (mean age 22.6 years, SD=3.2). The data were collected between 2002 
and 2010.  
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 5. CILENTO4, 5 —Italy. The Cilento study is a population-based study that includes 2,137 
individuals from three isolated populations of South Italy. Data from the NEO-PI-R 
questionnaire were available for 800 participants representing the final sample. Of this sample, 
64.4% were women. The mean age of all participants was 54.6 years (SD=19), of the males 54.6 
years (SD=19.2) and of the females 54.6 years (SD=19.5). The data were collected between 2009 
and 2011. 
 
6. EGCUT6 — Estonia. The Estonian cohort comes from the population-based biobank of the 
Estonian Genome Project of University of Tartu (EGCUT). The project is conducted according 
to the Estonian Gene Research Act and all participants have signed the broad informed consent 
(www.biobank.ee). In total, 52,000 individuals aged 18 years or older participated in this cohort 
(33% men, 67% women). General practitioners (GP) and physicians in the hospitals randomly 
recruited the participants. A Computer-Assisted Personal interview was conducted during 1–2 h 
at doctors’ offices. Data on demographics, genealogy, educational and occupational history, 
lifestyle and anthropometric and physiological data were assessed. The personality profile was 
assayed using NEO-PI-3 questionnaire and was administered to 1,730 participants. In this 
sample, the age range was 18–88 years (M=42.8 years, SD=16.5). The sample consisted of 740 
men (mean age 42 years, SD=16.3) and 991 women (mean age 43.4 years, SD=16.6). The 
genotyping was carried out in two waves for a random subsamples: 1) 1,183 samples using 
Illumina Human370CNV array and 2) 120 samples using Illumina OmniExpress array, resulting 
with an effective sample of 1,303. The data were collected between 2009 and 2012. 
 
7. ERF7 — The Netherlands. The Erasmus Rucphen Family (ERF) study is a family-based study 
including over 3,000 individuals from an isolated population in the Southwest region of the 
Netherlands. There were 2,400 individuals for whom both NEO personality and GWA data were 
available. The personality traits were assessed with the NEO-FFI. The mean age of all 
participants was 49.3 years (SD=14.9) and women constituted 55.8% of the total sample 
(M=49.0, SD=15.1, versus in men M=49.6, SD=14.7). 
 
3 
 
8+9. FINNISH TWINS EPI AND NEO 9, 10 — Finland. The Finnish twin cohort (FTC) consisted 
of 1381 genotyped respondents with personality data from two separate twin cohorts: the older 
Finnish twin cohort consisted of like-sexed twins born before 1958, and FinnTwin12 consisted of 
twins born in 1983-1987. A total of 567 individuals with available genotyping data (mean age 
25.5, SD 4.8; 32.9% women) from the older Finnish twin cohort completed the Eysenck 
Personality Inventory (EPI; an alternative version of the EPQ) at least once. EPI was assessed in 
1975-1976 and for the second time in 1981-1983. Some of the twins from the older Finnish twin 
cohort were assessed with the NEO-FFI between 2003-2009 as a part of the Nicotine Addiction 
Genetics (NAG) - Finland study. In addition, NEO-FFI was assessed also in the fourth wave of 
the FinnTwin12 study in 2005-2009. Combining participants from the NAG and FinnTwin12 
studies, the total number of genotyped individuals with the NEO-FFI data was 813 (mean age 
30.5, SD 15.3; 49.5% were women). All subjects were genotyped at the Welcome Trust Sanger 
Institute using the Illumina 670 Custom chip. 
 
10. HBCS8-10 — Finland. The Helsinki Birth Cohort Study (HBCS) is composed of 8,760 
individuals born between the years 1934 and 1944 in one of the two main maternity hospitals in 
Helsinki, Finland. Between 2001 and 2003, a randomly selected sample of 928 men and 1,075 
women participated in a clinical follow-up study with a focus on cardiovascular, metabolic and 
reproductive health, cognitive function and depressive symptoms. In 2004, various psychological 
phenotypes were assessed, including the NEO and TCI personality dimensions. There were 1 
698 participants that completed either the NEO and/or the TCI (55.9% women). The mean age of 
the subjects was 63.4 years (SD=2.9). The mean age of the men was 63.3 years (SD=2.7) and of 
the women was 63.5 years (SD=3).  
 
11. CROATIA-Korcula11 — Croatia. This study was performed in the eastern part of the island of 
Korčula, Croatia between March and December 2007. Healthy volunteers aged 18 and over from 
the town of Korčula and villages Lumbarda, Žrnovo, and Račišće were invited to the study. 
There was a total of 969 participants included who had a number of quantitative phenotypic traits 
measured. The EPQ-R was successfully administered to 810 participants (511 female; 63.1%). 
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The mean age was 55.4 years (SD=13.3; female M=54.5, SD=12.8, male M=56.9, SD=14). The 
data were collected in 2007. 
 
12. LBC192112 — United Kingdom. The Lothian Birth Cohort 1921 (LBC1921) study includes 
550 individuals born in 1921, most of whom had taken part in the Scottish Mental Survey of 
1932. The majority of participants lived independently in the Lothian region (Edinburgh city and 
surrounding area) of Scotland. Of these, 498 participants were approached to complete the IPIP 
personality inventory, and 478 participants (283 women; 59.2%) successfully did so. The mean 
age of both female and male participants was 81.2 (SD=0.3). IPIP data were collected twice: in 
2002 and between 2007 and 2008. Measurements from the first IPIP assessment were used for 
472 individuals, with second assessment measurements used for six individuals. DNA was 
extracted from blood samples and genotyped using the Illumina610-Quadv1 conducted by the 
Genetics Core Laboratory at the Wellcome Trust Clinical Research Facility, Western General 
Hospital, Scotland. Genotype and phenotype data were available for 437 individuals. 
 
13. LBC193612-14 — United Kingdom. The Lothian Birth Cohort 1936 (LBC1936) study 
comprises 1,091 individuals born in 1936, most of whom had taken part in the Scottish Mental 
Survey of 1947. The majority of participants lived independently in the Lothian region 
(Edinburgh city and surrounding area) of Scotland. Participants completed NEO-FFI and IPIP 
personality questionnaires at a mean age of 69.6 years (SD=.82; women M=69.6, SD=.82, men 
M=69.6, SD=.82); at 72.5 years (SD=.71; women M=72.5, SD=.72, men M=72.4, SD=.82) the 
IPIP was re-administered. IPIP data collection occurred between 2004 and 2007, and between 
2007 and 2010. First wave measurements were used for 963 individuals, and second wave 
measurements for 69 individuals. DNA was extracted from blood samples and genotyped using 
the Illumina610-Quadv1 conducted by the Genetics Core Laboratory at the Wellcome Trust 
Clinical Research Facility, Western General Hospital, Scotland. Genotype and phenotype data 
were available for 952 individuals. 
 
14. MCTFR15, 16 — United States of America. Data from the Minnesota Center for Twin and 
Family Research (MCTFR) were collected as part of two different longitudinal studies, the 
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Minnesota Twin Family Study (MTFS) and the Sibling Interaction and Behavior Study (SIBS). 
The MTFS is a study of reared-together, same-sex twins and their parents, and the SIBS is a 
study of families of different types (some include adopted offspring). Both parents and offspring 
completed the Multidimensional Personality Questionnaire (MPQ) at baseline, and only 
offspring completed it at subsequent follow-ups of approximately 3-year intervals. There were 
data available for up to 5 follow-ups for offspring in the MTFS and up to 3 for offspring in the 
SIBS. We selected data from the first assessment with complete data for each individual. The 
total sample with MPQ data included 9,071 participants (53% female), and of those participants, 
7,186 had both IRT-based extraversion scores and usable SNP data. The final sample included 
3,346 males (M age = 31.93, SD = 13.96) and 3840 females (mean age = 31.19, SD = 12.97).  
 
15. MGS – United States of America. Data derive from the “control” sample of a large 
schizophrenia study (Molecular Genetics of Schizophrenia (MGS): PI and Collaboration 
Coordinator, P.V. Gejman). The available sample consisted of unrelated subjects selected by 
random digit dialing from approximately 60,000 US households. They were screened for 
psychotic and bipolar disorders but were not excluded for other common psychiatric disorders 
seen in the general population. The European American sample (53% female) were adults with a 
mean age of 50 (SD=16.4) at assessment (Sanders, 2010). Subjects completed an on-line 
psychiatric screening interview that included the short form of the Eysenck Personality 
Questionnaire (EPQ-SF). The data were obtained with permission from dbGaP (Database of 
Genotypes and Phenotypes, http://www.ncbi.nlm.nih.gov/gap, Study Accessions: 
phs000021.v3.p2 (“GAIN”) and phs000167.v1.p1 “nonGAIN”). Data from the GAIN and 
nonGAIN European American subjects were combined for the current analyses (N=2,806).  
 
16. NBS17 — The Netherlands. In 2000 a study was initiated among the inhabitants of the 
municipality of Nijmegen by different departments of the Radboud University Nijmegen 
Medical Centre to research the question what the prevalence of certain risk factors, chronic 
diseases and genetic variations in the general population are. As a part of this study, the EPQ-R 
was administered to 1,832 participants. From this sample, 1,823 participants (921 female; 
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50.5%) completed the test. The mean age of these participants was 61.5 (SD=10.3; female 
M=56.7, SD=10.8, male M=66.3, SD=7). 
 
17. NESDA18 — The Netherlands. The NESDA data for the present study were drawn from the 
Netherlands Study of Depression and Anxiety18, an ongoing longitudinal cohort study aimed at 
examining the long-term course of depressive and anxiety disorders in different health care 
settings and phases of illness. A total of 2,981 respondents were recruited from primary care 
(n=1,610), specialized mental health care (n=807) and the community (n=564), including healthy 
controls, respondents with subthreshold symptoms and those with an anxiety and/or depressive 
disorder. The NEO-FFI was successfully administered to 2,961 participants (1,979 female; 
66.8%). The mean age was 41.9 years (SD=13.1; female M=41.1, SD=13.1, male M=43.4, 
SD=12.9). Baseline data were collected between 2004 and 2007. The NEO-FFI was administered 
twice, at baseline and two years later. For the NESDA sample, contrary to the other studies with 
repeated measure data of personality, we first selected the least recent item data. For NESDA, 
this strategy was deemed most suitable because the first measurement represented the baseline 
measurement for NESDA which had an overpresentation of MDD cases. So, we choose to 
measure personality at the time point at which MDD was least prevalent. 
 
18. NTR19, 20 — The Netherlands. Data on personality in the Netherlands Twin Register (NTR) 
were collected as part of a longitudinal study on health, personality and lifestyle in adolescent 
and adult twins and their relatives (i.e., their non-twin siblings, parents, spouses and children). 
Eight waves of data collection have been completed (in 1991, 1993, 1995, 1997, 2000, 2002, 
2004 and 2009). Twins were invited to participate at all time points, while the parents and 
siblings could participate on a maximum of 6 time points, spouses on 4 time points and adult 
children of twins and siblings on 2 time points. The ABV was administered five times in 1991, 
1993, 1997, 2000 and 2002, and the NEO-FFI was assessed twice in 2004 and 2009. Of the 
31,694 individuals who participated at least once in one of these seven waves, there were 31,259 
individuals (58.7% female) with valid personality data (at least one Extraversion item was 
available on at least one time point). For the analysis in this study, we selected for each 
individual the ABV item data of the latest time point and the NEO item data of the earliest time 
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point. This ensured that for each individual with data on both the ABV and NEO, the times of 
measurement were as close as possible. For 21,146 individuals there were NEO data available 
(of which from 14,880 individuals data came from the 2004 survey and from 6 266 individuals 
data came from the 2009 survey). For the ABV, data of 6,778 individuals came from survey 
2002, 1,803 from 2000, 5,088 from the 1997, 2 208 from 1993, and 2,939 from 1991 (in total 
18,816 individuals with ABV data). The mean age of the participants was 37.2 years (SD=15.3) 
across assessments. For the GWAS analysis we selected all participants with GWAS data, 
allowing first-degree relatives (e.g. sibling pairs and parent-offspring pairs), because a genetic 
relatedness of 0.5 can be accounted for in the GWAS analysis in PLINK by using the –family 
option. This led to the inclusion of 6,416 participants for the GWAS analysis. For the GCTA 
analysis, unrelated participants are required. Hence, we randomly selected one individual per 
family, yielding 3,597 individuals for the GCTA analysis. In the polygenic risk score analysis 
where we predicted Extraversion in the NTR cohort, we were able to deal with any degree of 
genetic relatedness by applying linear mixed modeling. Therefore, we included all subjects with 
personality and GWAS data, yielding 8,648 individuals in the analysis.  
 
19. ORCADES21 — United Kingdom. The Orkney Complex Disease Study (ORCADES) is a 
genetic epidemiology study based in an isolated population in the north of Scotland. It aims to 
discover the genes and variants in them that influence the risk of common, complex diseases 
such as diabetes, osteoporosis, stroke, heart disease, myopia, glaucoma, chronic kidney and lung 
disease. As a part of this study, the EPQ-R was administered to 1650 participants and all 
participants completed the test. The mean age of these participants was 56.8 (SD=13.8; women 
M=56.5, SD=13.9, men M=57, SD=13.8). The data were collected between 2007 and 2011. 
 
20. PAGES — Germany. In this German cohort, healthy control participants were randomly 
selected from the general population of Munich, Germany, and contacted by mail. Several 
screenings were conducted before the volunteers were enrolled in the study. These included 
screening of medical and psychiatric disorders (in particular psychotic disorders) in the 
participants and their first-degree relatives by phone and interview and screening for central 
nervous system and cognitive impairment by neurological examination and cognitive testing. 
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Furthermore, only participants with German descent (all four grandparents German) could 
participate. In the resulting sample, a large battery of personality questionnaires was 
administered as well as data on life events and traumatic events. Data on the NEO-PI-R and TCI 
were analyzed for the current study. There were 476 individuals (55.7% women) with valid 
personality data. The mean age of the sample was 45.9 years (SD=15,4; women M=43.4, 
SD=15,3, men M=49, SD=15,3). The data were collected between 1998 and 2006. 
 
21. QIMR adolescents — Australia Personality data collected between 1992 and 2011 were 
available for 4,100 adolescents and young adults (51.5% female), of which 2,842 (48.6% female) 
were genotyped. Participants included in the current study (with both phenotypic and genotypic 
data) ranged in age from 9 to 25 years (M=14.4, SD=2.3). The sample comprised twin pairs (and 
their siblings) recruited as adolescents as part of the overarching Brisbane Adolescent Twin 
Study22 conducted at the QIMR Berghofer Medical Research Institute (QIMR). Recruitment was 
mostly through primary and secondary schools in south-east Queensland for studies of 
melanocytic naevi (moles).23 JEPQ and/or NEO personality data (NEO-PI-R or NEO-FFI) were 
collected as part of the melanocytic naevi study (1992-ongoing), the cognition study (in-person 
testing, 1996-2012)22, a health and well-being study (a mail/phone study, 2002-2003)22, and a 
study of borderline personality disorder (online/paper survey, 2003–2006)24. JEPQ data were 
available at 3 time points, NEO-PI-R data at 1 time point, and NEO-FFI data at 2 time points. 
Data from the first time point (majority of sample) was retained for both JEPQ and NEO, with 
the NEO-PI-R given preference over the shorter NEO-FFI. DNA samples were collected in 
accordance with standard protocols and were genotyped on the Illumina 610 quad.25 
 
22. QIMR adults — Australia Personality data were available for a large Australian adult sample 
comprising 26,680 individuals (57.1% female), of which 7,201 (38.3% female) were genotyped. 
Participants included in the current study (with both phenotypic and genotypic data) ranged in 
age from 17 to 85 years (M=38.1, SD=12.6). Data were collected between 1980 and 2007 in 
various twin family studies conducted at QIMR.  
NEO personality data (NEO-PI-R or NEO-FFI) were collected from a series of studies 
conducted collaboratively by Nick Martin and Andrew Heath between 2001 and 200626, 27, 24. 
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The EPQ data were obtained from the following sources: (a) The Canberra study (1980-1981)28: 
twins drawn from the Australian Twin Registry and born prior to 1964 (‘Cohort 1’); (b) Two 
twin studies (1988-1991) in which Health and Lifestyle Questionnaires were sent to the members 
of Cohort 1 and an additional group born from 1964 to 1971 (‘Cohort 2’)30; with similar 
questionnaires also sent to immediate family members of the twins; (c) The Anxiety and 
Depression study (assessed twice, once by questionnaire and once by telephone interview)33 
drawn from Cohort 1 and Cohort 2 but selected to include mainly individuals with extreme high 
or low neuroticism scores from the studies in (b) and members of their immediate families. The 
TCI data were obtained from two twin studies (1988-1991) from Cohort 1 and 2, and the MPQ 
data as part of the Gambling Study (cohort 2).29  
Altogether, the EPQ was administered four times, the NEO-FFI twice, and the TCI, 
NEO-PI-R and MPQ once. Data from one time point per inventory per participant was retained, 
with time points chosen to minimize time difference. We first selected EPQ item data at first 
assessment, because the items were available for the majority of the subjects. TCI data was 
obtained at the same time point and the MPQ assessment was close in time. When available, the 
NEO-PI-R was chosen over the shorter NEO-FFI. The genotypic data used in the current study 
are derived from multiple waves of genotyping. DNA samples were collected in accordance with 
standard protocols and submitted to different genotype centres using different Illumina SNP 
platforms (317 single, 370 single, 370 duo, 670 quad, 610 quad).25 Phenotypic and genotypic 
data collections were approved by the QIMR Human Research Ethics Committee and informed 
consent was obtained from all participants. 
 
23. SAGE-COGA34, 35 — United States of America. The Collaborative Study on the Genetics of 
Alcoholism (COGA) is a multi-site study funded by the National Institute on Alcohol Abuse and 
Alcoholism (NIAAA) and National Institute on Drug Abuse (NIDA) that aims to characterize the 
familial transmission of alcoholism and related phenotypes and identify susceptibility genes. A 
total of 649 participants drawn from COGA completed the TCI, 647 of whom had corresponding 
genome-wide genotyping successfully performed as part of The Study of Addiction: Genetics 
and Environment (SAGE). SAGE is part of the Gene Environment Association Studies initiative 
funded by the National Human Genome Research Institute (NHGRI). The mean age of COGA 
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participants with both SAGE genotypes and TCI phenotypes was 40.8 years (SD=10.8) and 
women constituted 45.6% of the total sample (M=40.9, SD=10.4, versus in men M=40.8, 
SD=11.1). 
 
24. SAGE-COGEND5, 6 — United States of America. The Collaborative Genetic Study of 
Nicotine Dependence (COGEND) was initiated as a three-part program project grant funded 
through the National Cancer Institute (NCI; PI: Laura Bierut). The three projects included a 
study of the familial transmission of nicotine dependence, a genetic study of nicotine 
dependence, and a study of the relationship of nicotine dependence with nicotine metabolism. 
The primary goal is to detect, localize, and characterize genes that predispose or protect an 
individual with respect to heavy tobacco consumption, nicotine dependence, and related 
phenotypes and to integrate these findings with the family transmission and nicotine metabolism 
findings. As a part of this study, item-level NEO-FFI data were available from 2,712 
participants, 1,279 of whom had corresponding genome-wide genotyping successfully performed 
as part of The Study of Addiction: Genetics and Environment (SAGE). SAGE is part of the Gene 
Environment Association Studies initiative funded by the National Human Genome Research 
Institute (NHGRI). The mean age of COGEND participants with both SAGE genotypes and 
NEO-FFI phenotypes was 36.5 years (SD=5.6) and women constituted 65.1% of the total sample 
(M=36.6, SD=5.6, versus in men M=36.4, SD=5.5). 
 
25. SardiNIA – Italy. The SardiNIA study includes 6,148 related individuals from four towns in 
the Ogliastra province of Sardinia, Italy.21 These individuals represent 62% of the population in 
these towns. Valid personality data were available for 5,669 individuals, of which 3,972 were 
genotyped (56.7% women). The mean age of all participants was 42.8 years (SD=17). The mean 
age of the men was 43.0 years (SD=18), and of the women 42.4 years (SD=17). The sample has 
been described in more detail by Terracciano and co-authors.31 
 
26. SHIP – Germany. The Study of Health in Pomerania (SHIP) is a cross-sectional survey in 
West Pomerania, the north-east area of Germany30, 31. A sample from the population aged 20 to 
79 years was drawn from population registries. First, the three cities of the region (with 17,076 to 
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65,977 inhabitants) and the 12 towns (with 1,516 to 3,044 inhabitants) were selected, and then 17 
out of 97 smaller towns (with less than 1,500 inhabitants), were drawn at random. Second, from 
each of the selected communities, subjects were drawn at random, proportional to the population 
size of each community and stratified by age and gender. Only individuals with German 
citizenship and main residency in the study area were included. Finally, 7,008 subjects were 
sampled, with 292 persons of each gender in each of the twelve five-year age strata. In order to 
minimize drop-outs by migration or death, subjects were selected in two waves. The net sample 
(without migrated or deceased persons) comprised 6,267 eligible subjects. Selected persons 
received a maximum of three written invitations. In case of non-response, letters were followed 
by a phone call or by home visits if contact by phone was not possible. The SHIP population 
finally comprised 4,308 participants (corresponding to a final response of 68.8%). From 2007 to 
2010, the “Life-Events and Gene-Environment Interaction in Depression” (LEGEND) study was 
conducted.31 Until the beginning of LEGEND, 639 participants from the baseline sample SHIP-0 
were either deceased (n=383) or refused further participation (n=256). Thus, 3,669 participants 
were invited to take part in the LEGEND study. During the conduction of LEGEND 92 
participants were deceased and 1,011 subjects refused participation in the LEGEND study. 132 
subjects did not respond to repeated efforts of contact (at least three written invitations, 10 
telephone calls and five home visits). 35 subjects agreed to participate but missed all 
appointments. Among the 2,400 subjects who participated in the LEGEND study, we excluded 
134 subjects from the analyses because of unreliable information or inconsistencies in the 
interview according to the judgment of the interviewer and the supervisor. Full data sets (GWAS 
& extraversion) were available for 2,213 subjects. 
 
27. STR32 — Sweden. For the Swedish Twin Registry (STR) a cohort of twins born in 1926–67 
was compiled in 1970, by use of nationalized birth registrations. A register consisting all 50,000 
twin births was established. Members of like-sexed pairs from the cohort born in 1926–58 were 
sent a questionnaire in 1972–73. Responses were received from 36,535 individuals including 
14,000 twin pairs. The EPI was included to assess personality and completed by 30,276 
individuals (52.3% female). Among these individuals, 22,390 subjects were invited to the 
TwinGene study conducted between 2004 and 2008. In total, 12,591 (56%) individuals 
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participated by donating blood to the study, and by answering questionnaires about life style and 
health. DNA from 9,896 individual subjects was sent to Uppsala, Sweden for genome wide 
genotyping with Illumina OmniExpress bead chip (all available dizygous twins + one twin from 
each available MZ twin pair). Genotyping results for 9,836 subjects and 731,442 autosomal 
SNPs passed the initial lab-based quality control (QC). In further QC, SNPs with more than 3% 
missing information (GENO > 0.03) (n=3,922), a minor allele frequency below 1% (n=79,893), 
or a Hardy-Weinberg equilibrium (HWE) test p-value <= 1e-07 (n=3,071), were excluded. 
Individuals with low genotyping success (MIND > 0.03) (n=10), heterozygosity of X-
chromosomes in males (n=36), deviations in heterozygosity of more than 5 standard deviations 
(SD) from the population mean (n=49), or detection of unknown (cryptic) relatedness (n=124), 
were excluded. After the QC there were 9,617 individuals and 644,556 autosomal SNPs 
remaining.  
28. CROATIA-Vis33 — Croatia. Adult participants living in the villages of Komiža and Vis on 
the Croatian island of Vis were recruited in May 2003 and May 2004 for a large genetic study. 
Croatia has 15 Adriatic Sea islands with populations greater than 1,000. The villages on the 
islands have unique population histories and have preserved their isolation from other villages 
and the outside world through many centuries. Informed consents, procedures and questionnaires 
were reviewed and approved by relevant ethics committees in Scotland and Croatia. All 
individuals over 18 years old and resident on the Island of Vis were invited to participate in this 
study. More information about this sample can be found in 33. As a part of the interview 
participants also completed the Eysenck Personality Questionnaire-Revised (short-form; EPQ-
R). Seventy percent of the villages’ adult population took part in the study, a total of 918 
individuals (531 female; 57.8%), 9 of whom have all missing data. The mean age was 56.4 years 
(SD=15.5; female M=56.7, SD=16, male M=55.9, SD=14.9). The data were collected between 
2003 and 2004. 
 
29. YOUNG FINNS34 — Finland. The Young Finns study (YFS) is an ongoing, population-based 
prospective cohort study started in 1980 with a baseline sample of 3,596 children and 
adolescents derived from six birth cohorts aged 3, 6, 9, 12, 15, and 18 years at baseline 
(http://youngfinnsstudy.utu.fi/). The participants were recruited from five areas according to 
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locations of university cities with a medical school (Helsinki, Kuopio, Oulu, Tampere and 
Turku). In each location, individuals from urban and surrounding rural areas were selected at 
random from the population registry (based on their unique personal social security number 
from) to be invited in the study. Subsequent data collection waves have been carried out in 1983, 
1986, 1989, 1992, 1997, 2001, 2007 and 2012. Personality data for the NEO-FFI were collected 
with mailed questionnaires in 2007 from 2,058 participants of whom 2,057 were included in the 
study with NEO-FFI data (one participant had all missing data). The mean age of participants 
was 37.6 years (SD=5) for women and men at the time of personality assessment, and 1,212 
participants (58.9%) were female. 
 
30. GENERATION SCOTLAND: SCOTTISH FAMILY HEALTH STUDY35  – Scotland (United 
Kingdom). The Generation Scotland: Scottish Family Health Study (GS:SFHS) is a collaboration 
between the Scottish Universities and the NHS, funded by the Chief Scientist Office of the 
Scottish Government. GS:SFHS is a family-based genetic epidemiology cohort with DNA, other 
biological samples (serum, urine and cryopreserved whole blood) and socio-demographic and 
clinical data from ~24,000 volunteers, aged 18-98 years, in ~7,000 family groups. Participants 
were recruited across Scotland, with some family members from further afield, from 2006 - 
2011. Most (87%) participants were born in Scotland and 96% in the UK or Ireland. GS:SFHS 
operates under appropriate ethical approvals, and all participants gave written informed consent. 
From this cohort, 9,860 individuals were successfully genotyped using the Illumina 
OmniExpress + Exome genotyping array. 1000 genomes SNP dosages were imputed using 
SHAPEIT_v2 and IMPUTE2 in conjunction with the Phase I integrated variant set release (v3) 
all ethnicities reference panel (MAR 2012). Extraversion was measured by the Eysenck 
Personality Questionnaire Revised Short Form, a self-report questionnaire requiring a yes/no 
response on 24 items. Extraversion questionnaire data were obtained for 9,783 individuals who 
also had 1000G imputed genotype data available. Summed questionnaire scores were used for 
association analysis of the selected replication SNPs using ProbABEL from the GenABEL suite 
of programs (www.genabel.org).36 
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Personality assessment 
Item data from the following personality inventories were included: the Neuroticism 
Extraversion Openness to Experience personality inventory revised (NEO-PI-R; 240 items, 48 
items for Extraversion), the abbreviated NEO Five Factor Inventory (NEO-FFI; 60 items, 12 
Extraversion items), the 30-item short version of the NEO-Five-Factor Model (NEO-FFI-30), the 
Eysenck Personality Questionnaire Revised (EPQ-R; 48 items, 12 items for Extraversion), the 
Junior EPQ (JEPQ; 81 items, 24 Extraversion items), the Eysenck Personality Inventory (EPI; 20 
items, 9 for Extraversion), the EPI-based Amsterdamse Biografische Vragenlijst (ABV; 21 
Extraversion items), the Big Five item set of the International Personality Item Pool (IPIP; 50 
items, 10 items for Extraversion), the Temperament and Character Inventory version 9 (TCI; 240 
items, of which 7-13 items were selected for Extraversion) and the Multidimensional Personality 
Questionnaire (MPQ; 198 items, of which 72 items were selected for Extraversion). The number 
of items included per cohort varied slightly; for the complete overview, see Van den Berg et al. 
(2014)37.  
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Supplementary Table 1. Genotyping and imputation in the 29 discovery cohorts and 1 replication cohort of the Genetics of 
Personality Consortium 
 Cohort Genotyping 
platforms(s) 
HWE P-
value * 
SNP 
call rate 
* 
Sample call 
rate * 
Imputation 
reference 
set 
Imputation 
software 
Association software 
 
1 ALSPAC Illumina 550K >5 x 10-7 >0.95 >0.97 1000G MACH MACH2QTL 
2 BLSA Illumina 550K ≥1 x 10-5 ≥0.99 ≥0.985 1000G MACH Merlin-offline 
3 BRESCIA Affymetrix 6.0 >1 x 10-6 >0.95 >0.96 1000G IMPUTE SVS 7 GoldenHelix 
4 CHICAGO Affymetrix 6.0 >1 x 10-4 >0.95 >0.90 1000G IMPUTE SNPTEST 
5 CILENTO Illumina 370 K            
Illumina 
OmniExpress 700K  
NA >0.95 >0.90 1000G MACH /minimac R, GenABEL 
/ProbABEL  
6 EGCUT Illumina 
Human370CNV & 
OmniExpress770k 
>1 x 10-6 >0.95 >.095 1000G IMPUTE SNPTEST 
7 ERF Illumina 318K, 
370K, 610K 
>1 x 10-6 ≥0.95 ≥0.95 1000G  minimac  ProbABEL 
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8 FTC EPI Illumina 670K >1 x 10-6  >0.95  > 0.95 1000G IMPUTE  SNPTEST 
9 FTC NEO Illumina 670K >1 x 10-6  >0.95  >0.95 1000G IMPUTE  SNPTEST 
10 HBCS Modified Illumina 
610 k 
>1 x 10-6 >0.95 >0.95 1000G MACH Plink, ProbABEL 
11 CROATIA-
Korcula 
Illumina HumanHap 
370 CNV Duochip 
>1 x 10-6 >0.98 >0.97 1000G ShapeIT /  
IMPUTE 
ProbABEL 
12 LBC1921 Illumina610-Quadv1  >1 x 10-3 ≥0.98 ≥0.95 1000G Minimac MACH2QTL 
13 LBC1936 Illumina610-Quadv1  >1 x 10-3 ≥0.98 ≥0.95 1000G Minimac MACH2QTL 
14 MCTFR Illumina 
Human660W-Quad 
Array 
>1 x 10-7 >0.99 removed 
samples 
with: non-
calls in 
more than 
5000 
markers; 
GenCall_10 
< .75; 
GenCall_50 
1000G Beagle / Minimac RFGLS package for R 
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< .9009 
15 MGS Affymetrix 6.0 >1 x 10-6 >0.98 No 
exclusions; 
all were > 
0.99 
1000G SHAPEIT / 
IMPUTE 
ProbABEL 
16 NBS Illumina 317K >1 x 10-6 >0.95 0.9 1000G MACH/minimac mach2qtl 
17 NESDA Affymetrics 5.0-
Perlegen  
Affymetrix 6.0  
Affymetrix 6 907k  
>1 x 10-6 >0.95 >0.9 1000G  IMPUTE PLINK 
18 NTR 
Affymetrics 5.0-
Perlegen  
Illumina 370  
Illumina 660 
Affymetrix 6.0  
Affymetrix 6 907k  
Illumina Omni 
Express 1M 
>1 x 10-6 0.95 0.9 1000G  IMPUTE PLINK 
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19 ORCADES 
Illumina HAP300 
854 subjs 
Illumina OmniX 
1067 Subjs 
Illumina Omni1 301 
Subjs  
>1 x 10-6 >0.97 >0.98 1000G  ShapeIT /  
IMPUTE 
R, 
GenABEL/ProbABEL 
20 PAGES  Illumina Human 
Hap 300 
>1 x 10-6 >0.99 >0.96 1000G MACH / minimac SNPTEST 
21 QIMR 
adolescents 
Illumina 610 quad >1 x 10-6 >0.95 >0.95 1000G  
(less SNPs 
with <2 
copies of 
minor allele 
in reference 
populations) 
MACH / minimac Merlin-offline 
22 QIMR 
adults 
Illumina 610 quad  
Illumina 670 quad  
Illumina 370 duo 
Illumina 370 single 
>1 x 10-6 >0.95 >0.95 1000G (less 
SNPs with 
<2 copies of 
minor allele 
MACH / minimac  Merlin-offline 
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Illumina 317 single in reference 
populations) 
23 SAGE-
COGA 
Illumina 1M >1 x 10-6 >0.95 >0.95 1000G IMPUTE SNPTEST 
24 SAGE 
COGEND 
Illumina 1M >1 x 10-6 >0.95 >0.95 1000G IMPUTE SNPTEST 
25 SardiNIA Affymetrix 10k, 
500k, 1M 
≥1 x 10-7 ≥0.95 ≥0.95 1000G MACH EPACTS Q.EMMAX 
26 SHIP Affymetrix 6.0 >1 x 10-4 >0.8 >0.92 1000G IMPUTE SNPTEST 
27 STR Illumina 
OmniExpress 
>1 x 10-6 >0.97 >0.97 1000G IMPUTE PLINK 
28 CROATIA-
Vis 
Illlumina Infinium 
HumanHap 300 
Bead chip 
>1 x 10-6 >0.98 >0.97 1000G ShapeIT /  
IMPUTE  
ProbABEL 
29 YFS Custom Illumina 
Human 670k 
BeadChip 
>1 x 10-6 ≥0.95 ≥0.95 1000G  IMPUTE SNPTEST 
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30 GS:SFHS Illumina 
OmniExpress + 
Exome genotyping 
array 
NA NA NA 1000G ShapeIT /  
IMPUTE 
ProbABEL 
* Quality control of genotyped SNPs prior to imputation (Inclusion criteria) 
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Supplementary Table 2. Genomic inflation factors (Lambda’s) for Extraversion results in each 
discovery cohort participating in the Genetics of Personality Consortium 
  
Cohort Lambda  Cohort Lambda  
ALSPAC 0.96 NBS 0.97 
BLSA 0.98 NESDA 0.97 
BRESCIA 0.98 NTR 0.99 
CHICAGO 0.98 ORCADES 0.97 
CILENTO 0.96 PAGES 0.96 
EGCUT 0.99 QIMR adolescents 0.98 
ERF 0.97 QIMR adults 0.97 
FTC EPI 0.96 SAGE-COGA 0.90 
FTC NEO 0.98 SAGE-COGEND 0.90 
HBCS 0.96 SardiNIA 0.99 
CROATIA-
Korcula 
0.97 SHIP 0.98 
LBC1921 0.98 STR 0.99 
LBC1936 0.98 CROATIA-Vis 0.97 
MCTFR 0.99 YFS 0.96 
MGS 0.96 Meta-analysis 1.02 
  
22 
 
Supplementary Table 3. Top 74 SNPs from meta-analysis of GWA results for Extraversion in the Genetics of Personality 
Consortium (P < 1*10-5)  
     Results meta-analysis discovery cohorts Results replication cohort 
SNP Chr_bp A1 A2 MAF Number of 
cohorts 
Effect SE P-value Effect SE P-value 
rs2024488 2_217662968 a g 0.30153 28 -0.0303 0.0059 2.939E-07 .0285 .0164342 .082442 
rs2712162 2_217661788 t c 0.30246 28 -0.0300 0.0059 3.872E-07 .0278 .0163777 .089472 
rs797182 12_10900487 a g 0.36128 28 -0.0277 0.0056 6.673E-07 -.0135 .0152612 .377213 
rs8010306 14_37150160 a g 0.05989 16 0.0629 0.0128 8.730E-07 .0180 .0313783 .566502 
rs117292860 19_2227621 a c 0.17926 20 0.0553 0.0113 9.191E-07 -.0350 .0239138 .143687 
rs79870297 4_186614953 t c 0.23932 28 -0.0323 0.0066 9.921E-07 -.0203 .0173826 .243252 
rs1088236 12_10899740 t g 0.35622 28 -0.0270 0.0056 0.000001235 -.0146 .0152161 .338657 
rs79953023 4_186603023 t g 0.25198 28 0.0315 0.0065 0.000001517 .0091 .0171432 .594888 
rs811615 12_10900541 t c 0.35554 28 -0.0268 0.0056 0.000001591 -.0147 .0152693 .334701 
rs797183 12_10900554 a c 0.35562 28 0.0268 0.0056 0.000001595 .0147 .0152676 .336788 
rs8012165 14_37150410 a t 0.05947 16 -0.0597 0.0125 0.000001907 -.0235 .0316400 .456751 
rs11053926 12_10901028 t c 0.35173 28 0.0265 0.0056 0.000002094 .0148 .0153021 .334706 
rs797184 12_10900925 a g 0.35076 28 0.0264 0.0056 0.000002300 .0153 .0152901 .318429 
rs79427853 4_186611819 a g 0.25172 28 0.0302 0.0064 0.000002369 .0130 .0169092 .441163 
rs2415358 14_37151869 a g 0.05871 16 0.0591 0.0125 0.000002402 .0207 .0316925 .512795 
rs4513000 14_37151542 t c 0.05837 16 -0.0590 0.0125 0.000002573 -.0215 .0316673 .497696 
rs28713249 14_37151057 t g 0.05837 16 0.0589 0.0125 0.000002616 .0224 .0316611 .479992 
rs932570 20_61028986 t c 0.45229 28 -0.0282 0.0060 0.000002711 -.0262 .0158993 .098807 
rs4477602 14_37151655 a g 0.05839 15 -0.0598 0.0128 0.000002778 -.0207 .0317595 .515553 
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     Results meta-analysis discovery cohorts Results replication cohort 
SNP Chr_bp A1 A2 MAF Number of 
cohorts 
Effect SE P-value Effect SE P-value 
rs10136792 14_37151212 a g 0.05833 16 -0.0588 0.0125 0.000002780 -.0221 .0316638 .485261 
rs4474609 14_37151117 a g 0.05833 16 -0.0587 0.0125 0.000002836 -.0223 .0316622 .482056 
rs12109897 5_172628038 a g 0.07341 21 -0.0490 0.0105 0.000002965 .0141 .0257128 .583425 
rs797177 12_10894916 a g 0.34982 28 0.0258 0.0055 0.000003297 .0138 .0150477 .360741 
rs797176 12_10894685 a t 0.34964 28 0.0256 0.0055 0.000003828 .0138 .0150350 .359432 
rs7002652 8_93282549 a c 0.46037 27 -0.0250 0.0054 0.000004093 -.0256 .0148972 .085817 
rs13282281 8_93297037 a c 0.42965 27 -0.0251 0.0055 0.000004124 -.0255 .0149594 .088092 
rs7300727 12_10902579 a g 0.32812 28 0.0262 0.0057 0.000004149 .0195 .0157664 .216274 
rs140417730 15_100587525 a g 0.07567 7 -0.1226 0.0266 0.000004173 .0186 .0420539 .658813 
rs2339583 8_93274702 c g 0.44775 27 -0.0250 0.0054 0.000004254 -.0234 .0148983 .117016 
rs13410278 2_168641637 a g 0.04252 10 -0.0685 0.0149 0.000004382 -.0266 .0378979 .482464 
rs13280948 8_93269692 a g 0.44223 27 -0.0250 0.0054 0.000004402 -.0238 .0149265 .111291 
rs1030064 2_217665966 t g 0.2976 28 -0.0273 0.0060 0.000004424 .0284 .0164976 .085092 
rs6442336 3_12870886 t c 0.24878 29 0.0304 0.0066 0.000004841 .0178 .0177543 .316834 
rs797179 12_10895357 a g 0.19118 28 0.0321 0.0070 0.000005113 -.0041 .0183290 .823724 
rs12681205 8_93298074 a c 0.42747 27 -0.0249 0.0055 0.000005453 -.0255 .0149543 .088361 
rs3732679 3_12867485 a c 0.32128 29 0.0278 0.0061 0.000005530 .0154 .0162908 .344030 
rs7144276 14_37144607 a t 0.01194 19 0.0527 0.0116 0.000005632 .0262 .0320563 .413166 
rs76669452 8_49756520 a g 0.07563 20 -0.0451 0.0099 0.000005645 -.0490 .0255501 .054907 
rs75245863 2_1960391 t c 0.12107 25 0.0400 0.0088 0.000005714 .0043 .0233747 .854378 
rs56095028 13_56060991 a g 0.06138 24 0.0485 0.0107 0.000006418 -.0060 .0237105 .799023 
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     Results meta-analysis discovery cohorts Results replication cohort 
SNP Chr_bp A1 A2 MAF Number of 
cohorts 
Effect SE P-value Effect SE P-value 
rs3732680 3_12873265 a g 0.23563 29 -0.0296 0.0066 0.000006539 -.0213 .0178185 .232522 
rs42385 16_6536933 a c 0.31747 28 -0.0266 0.0059 0.000006916 .0177 .0157367 .259704 
rs10891937 11_116126804 a g 0.40532 29 -0.0246 0.0055 0.000006940 -.0077 .0150088 .608712 
rs12668816 7_996398 t c 0.24545 20 -0.0484 0.0108 0.000007000 .0122 .0202365 .547203 
rs1444504 8_93279552 t c 0.46102 27 -0.0244 0.0054 0.000007039 -.0247 .0148723 .096628 
rs78961361 19_53267419 t g 0.06948 12 -0.0906 0.0202 0.000007198 -.0043 .0309257 .888678 
rs9940817 16_6535942 t c 0.31698 28 0.0266 0.0059 0.000007215 -.0186 .0157347 .236609 
rs35682092 16_6536593 a g 0.31724 28 0.0266 0.0059 0.000007325 -.0180 .0157413 .252854 
rs3095263 16_6536110 a g 0.31706 28 -0.0266 0.0059 0.000007361 .0186 .0157377 .238096 
rs118072569 10_13746323 a c 0.0306 5 0.1149 0.0256 0.000007418 .1249 .0446190 .005124 
rs1030065 2_217665415 a g 0.29752 28 -0.0267 0.0060 0.000007438 .0280 .0165086 .081040 
rs3849571 3_81777716 a c 0.35137 28 -0.0253 0.0057 0.000007918 -.0238 .0155870 .127118 
rs4392874 8_93271095 a g 0.44681 27 0.0243 0.0054 0.000007925 .0238 .0148728 .109583 
rs4786873 16_6539512 t g 0.3085 28 -0.0265 0.0059 0.000008048 .0061 .0159255 .702294 
rs7620240 3_81762787 t g 0.33795 28 0.0250 0.0056 0.000008248 .0234 .0155269 .131664 
rs4684887 3_12865617 t c 0.34277 29 -0.0272 0.0061 0.000008441 -.0179 .0161063 .266651 
rs13071278 3_82020103 t g 0.32278 28 -0.0260 0.0058 0.000008441 -.0268 .0159709 .093089 
rs4684115 3_12865329 a g 0.33409 29 -0.0272 0.0061 0.000008479 -.0177 .0161028 .272795 
rs668013 18_77407516 a g 0.47749 19 -0.0365 0.0082 0.000008684 .0070 .0161784 .665188 
rs2029785 1_79960085 a g 0.23686 27 -0.0286 0.0064 0.000008707 -.0499 .0178715 .005277 
rs9869182 3_12893668 t c 0.27393 29 -0.0292 0.0066 0.000008805 -.0294 .0177514 .097773 
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     Results meta-analysis discovery cohorts Results replication cohort 
SNP Chr_bp A1 A2 MAF Number of 
cohorts 
Effect SE P-value Effect SE P-value 
rs3772896 3_81751968 t c 0.33958 28 0.0249 0.0056 0.000008927 .0230 .0155311 .138186 
rs917647 16_6538699 t c 0.31746 28 -0.0261 0.0059 0.000009042 .0015 .0158747 .924204 
rs6442333 3_12864386 t c 0.30788 29 -0.0269 0.0061 0.000009107 -.0116 .0160892 .472272 
rs17790751 13_51875153 a g 0.05135 18 -0.0594 0.0134 0.000009113 .0113 .0314520 .718641 
rs3894895 3_12888976 t c 0.23674 29 -0.0292 0.0066 0.000009138 -.0218 .0180256 .227330 
rs4684886 3_12865282 c g 0.31607 29 0.0270 0.0061 0.000009154 .0137 .0161144 .396798 
rs4429609 3_12862561 t c 0.28902 29 -0.0277 0.0063 0.000009499 -.0120 .0159632 .453836 
rs7621968 3_81951460 a g 0.36606 28 -0.0250 0.0056 0.000009523 -.0138 .0153777 .370517 
rs114675436 1_80088978 a g 0.19177 27 -0.0355 0.008 0.000009533 -.0549 .0216094 .011088 
rs3821548 3_81758728 c g 0.33971 28 0.0248 0.0056 0.000009629 .0232 .0155295 .135226 
rs11783791 8_49724699 t c 0.09083 20 -0.0423 0.0096 0.000009932 -.0304 .0238159 .201441 
rs6789964 3_12864949 t c 0.32412 29 -0.0269 0.0061 0.000009950 -.0152 .0160204 .341443 
rs13340130 3_81790970 a t 0.34957 28 -0.0254 0.0058 0.000009985 -.0259 .0156925 .098580 
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 Supplementary Table 4. Top 30 genes from meta-analysis of GWA results for Extraversion in 
the Genetics of Personality Consortium (P < 1*10-5) 
 
Gene Nominal p-value Chromosome 
LOC101928162 0.00000287 12 
LOC729506 0.00000893 5 
PLEKHJ1 0.0000132 19 
POU2F3 0.0000179 11 
CRTAC1 0.0000297 10 
RELN 0.0000569 7 
PAX9 0.0000715 14 
ADAM12 0.0000765 10 
CYP2W1 0.0000916 7 
BDNF-AS 0.0001 11 
DNAH9 0.00012 17 
PDE3A 0.00012 12 
SORBS2 0.00012 4 
LINC00434 0.00014 13 
NDUFA4 0.00014 7 
SNORA7A 0.00015 3 
CAND2 0.00016 3 
MIR6814 0.00018 21 
NCMAP 0.00019 1 
ADAM29 0.00019 4 
IL34 0.0002 16 
CHTF8 0.00021 16 
NKX6-1 0.00022 4 
LOC100131655 0.00023 18 
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PAPD4 0.00023 5 
MIR4321 0.00024 19 
TP63 0.00029 3 
BDNF 0.0003 11 
COX19 0.0003 7 
MTMR9 0.00031 8 
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 Supplementary Figure 1. Manhattan plots for Extraversion results in each cohort participating 
in the Genetic of Personality Consortium 
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Supplementary Figure 2. Quantile-Quantile plots for Extraversion results in each cohort 
participating in the Genetic of Personality Consortium 
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